MedTrace Logo

Molecularly Aided Stratification for Tumor Eradication Research

NCT05852522 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-03-04

No results posted yet for this study

Summary

NCT/DKFZ/DKTK MASTER is a prospective, continuously recruiting, multicenter observational study for biology-guided stratification of adults with rare cancers, including rare subtypes of common entities, using comprehensive molecular profiling, and clinical decision-making in a multidisciplinary molecular tumor board.

Conditions

Sponsors & Collaborators

  • German Consortium for Translational Cancer Research

    collaborator OTHER

  • German Cancer Research Center

    lead OTHER

Principal Investigators

  • Stefan Fröhling, M.D. · German Cancer Research Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-11
Primary Completion
2028-10-31
Completion
2029-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05852522 on ClinicalTrials.gov